SciELO - Scientific Electronic Library Online

 
vol.42 número1Ecología de enfermedades infecciosas emergentes y conservación de especies silvestres índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Archivos de medicina veterinaria

versión impresa ISSN 0301-732X

Resumen

CHAVEZ, H; ARAYA, O; FOLCH, H  y  MORAN, G. Use of biomarkers for the diagnosis of joint disease in horses. Arch. med. vet. [online]. 2010, vol.42, n.1, pp.1-10. ISSN 0301-732X.  http://dx.doi.org/10.4067/S0301-732X2010000100002.

Lameness associated to joint disease (JD) in athlete equines is an important cause of economic losses. Intensive training produces biomechanical overload of the synovial joints with a consequent activation of metalloproteinases, which have been associated to the pathogenesis of equine JD. This disease is characterized by the degradation of the extracellular matrix (ECM) of the articular cartilage causing the release of structural components of the cartilage matrix to the joint space and producing changes in the synovial fluid concentration of these ECM components, termed biomarkers. The changes in the concentration of some of these proteins in the synovial fluid might be used to evaluate both the onset and progression of equine JD. The measurement of the levels of aggrecan and collagen type II in the synovial fluid using specific monoclonal antibodies is an example of this approach. This review presents an update on biomarkers used for equine JD.

Palabras clave : joint disease; biomarkers; synovial fluid; horse.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons